Drug/Drug Interactions With F901318
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
- Status
- TERMINATED
- Phase
- PHASE2
Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
- Status
- WITHDRAWN
- Phase
- PHASE3
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen
- Status
- TERMINATED
- Phase
- PHASE4
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- NA
Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1
De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study
- Status
- WITHDRAWN
- Phase
- PHASE3
A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
- Status
- COMPLETED
- Phase
- NA
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
- Status
- TERMINATED
- Phase
- PHASE2
Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4